Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in Brunei Darussalam has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Brunei Darussalam have played a crucial role in shaping the growth of the Other OTC Pharmaceuticals (Pharmacies) market. Bruneians have shown a growing interest in self-medication and taking care of their own health. This preference for self-care has led to an increased demand for over-the-counter pharmaceutical products that can be easily accessed in pharmacies without a prescription. Additionally, Bruneians have also shown a preference for natural and herbal remedies, leading to a surge in the demand for alternative medicine products in the market. Trends in the market have also contributed to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Brunei Darussalam. With the advancement of technology and the increasing availability of information, consumers have become more aware of the various options available to them. This has led to a shift towards products that are perceived to be more effective, safe, and convenient. As a result, pharmacies in Brunei Darussalam have been expanding their product offerings to meet the evolving demands of their customers. This includes introducing new and innovative over-the-counter pharmaceutical products to cater to specific health needs. Local special circumstances have also played a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Brunei Darussalam. The country's small population and high disposable income have created a favorable environment for the growth of the market. Bruneians have the financial means to afford over-the-counter pharmaceutical products and are willing to spend on their health and well-being. Additionally, the government of Brunei Darussalam has implemented policies to promote the development of the healthcare sector, including the expansion of pharmacies and the availability of a wide range of over-the-counter pharmaceutical products. Underlying macroeconomic factors have further fueled the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Brunei Darussalam. The country's stable economy and high standard of living have contributed to increased consumer spending on healthcare products. Additionally, the government's focus on promoting a healthy lifestyle and preventive healthcare has created a favorable environment for the growth of the market. Brunei Darussalam's strategic location in Southeast Asia has also attracted international pharmaceutical companies to establish a presence in the country, further driving the growth of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Brunei Darussalam is developing due to customer preferences for self-care and natural remedies, trends in the market towards more effective and convenient products, local special circumstances such as a small population and high disposable income, and underlying macroeconomic factors including a stable economy and government support for the healthcare sector.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
